Matthew L. Posard, Director: Halozyme Therapeutics HALO Sell · Filed 24/08/14

Trade details

Type: Insider sale
Amount: $570,133.7
Shares · price: 9,881 sh · $57.70 a share
Held after: 69,874 sh
Stock: Halozyme Therapeutics HALO
Person: Matthew L. PosardDirector
Trade date: 24/08/14
Filed: 24/08/14
Days to filing: 0 days

Sold 12.4% of holdings

Share of holding sold: 12.4%

Halozyme Therapeutics trades, last 26 weeks

What else happened in Halozyme Therapeutics around then

Filed or reported within 30 days of the trade day · 24/07/15~24/09/13

Matthew L. Posard's recent trades

Matthew L. PosardDirector
Planned sale10b5-1 planHalozyme Therapeutics
Planned sale10b5-1 plan
Halozyme Therapeutics
HALO
$3.6M
34,226 sh
$3.6M
Filed 09/16
Traded 09/16
Matthew L. PosardDirector
SellHalozyme Therapeutics
Sell
Halozyme Therapeutics
HALO
$561.9K
10,000 sh
$561.9K
Filed 24/08/14
Traded 24/08/13
Matthew L. PosardDirector
SellHalozyme Therapeutics
Sell
Halozyme Therapeutics
HALO
$557.2K
10,000 sh
$557.2K
Filed 24/08/14
Traded 24/08/12
Matthew L. PosardDirector
SellHalozyme Therapeutics
Sell
Halozyme Therapeutics
HALO
$506.2K
10,000 sh
$506.2K
Filed 24/06/13
Traded 24/06/12
Matthew L. PosardDirector
SellHalozyme Therapeutics
Sell
Halozyme Therapeutics
HALO
$500.1K
10,000 sh
$500.1K
Filed 24/06/13
Traded 24/06/11

Matthew L. Posard, Director — sold $570.1K of Halozyme Therapeutics HALO · 12.4% of holdings | Whalegun